Supreme Court Will Rule on Availability of Abortion Pill
By Dennis Thompson HealthDay Reporter
WEDNESDAY, Dec. 13, 2023 -- The Supreme Court will review the ability of American women to easily access a commonly used abortion pill, the court announced Wednesday.
Mifepristone has become central to the response by health care professionals and reproductive rights advocates to last year’s Supreme Court decision overturning Roe v. Wade.
The pill can be transported across state and national borders, allowing women to skirt efforts to ban or severely restrict abortion in some states.
The U.S. Food and Drug Administration approved mifepristone more than two decades ago, and it is currently used in more than half of all pregnancy terminations in the United States, the New York Times reported.
Policies issued in recent years by the FDA have allowed the pills to be prescribed via telehealth, mailed to patients and handed out at pharmacies.
Before that, the pill had to be prescribed by a doctor and picked up in person. Patients also had to visit a doctor three times during the medication abortion process, the Times reported.
Anti-abortion rights activists originally sued to block FDA approval of mifepristone entirely, but in August the conservative U.S. Fifth District Court of Appeals overturned only the more recent policies expanding access.
The appeals court ruled that the FDA did not follow proper procedures when it loosened regulations for obtaining the pill, the Times reported.
The Biden administration and mifepristone manufacturer Danco Laboratories appealed the Fifth District’s decision to the Supreme Court, which has agreed to hear arguments regarding those policies, its order states.
The high court will not review the FDA’s original approval of the drug.
In its appeal, lawyers from the Justice Department said allowing the Fifth District decision to stand “would threaten to severely disrupt the pharmaceutical industry and prevent F.D.A. from fulfilling its statutory responsibilities according to its scientific judgment,” the Times reported.
In a brief, the conservative Christian legal advocacy group Alliance Defending Freedom called the appeals court’s ruling a “modest decision” that “merely restores the common-sense safeguards under which millions of women have taken chemical abortion drugs,” the Times said.
Sources
- New York Times
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
About 8,000 Women Per Month Are Getting Abortion Pills Despite Their States' Bans
TUESDAY, May 14, 2024 -- While some states have moved to severely curb women's access to abortion, including abortion pills, over 8,000 women living in those states are getting...
Getting Abortion Pill Via Mail Order Is Quick, Safe & Effective
MONDAY, May 13, 2024 -- Women who get abortion pills through the mail receive care that's as good as those who are required to get them in person from a clinic or doctor’s...
1 in 4 U.S. Women Will Have an Abortion in Their Lifetime
TUESDAY, April 30, 2024 -- As the battle over abortion continues to rage in the courts and American politics, a new report estimates that one in every four U.S. women will undergo...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
